PATEL CHEM SPECIALITIES IPO is a fully book-built SME issue with a total size of approximately ₹58.80 crores. The offering comprises a fresh issue of 7,000,000 equity shares.
The IPO will open for subscription on July 25, 2025 and close on July 29, 2025.
The allotment process is expected to be finalized by July 30, 2025. The PATEL CHEM SPECIALITIES IPO is scheduled to list on the BSE SME platform on August 1, 2025.
The price band has been set at ₹82 to ₹84 per share. The lot size is 1,600 shares, requiring a minimum investment of ₹134,400.
Registrar for this IPO is Link Intime India Private Limited and lead managers are Cumulative Capital Private Limited and Unistone Capital Private Limited.
Explore more upcoming IPOs in India for comparison and investment planning.
IPO Schedule
| IPO Open Date | Friday, 25 Jul, 2025 |
|---|---|
| IPO Close Date | Tuesday, 29 Jul, 2025 |
| IPO Allotment Date | Wednesday, 30 Jul, 2025 |
| Refund Initiation | Thursday, 31 Jul, 2025 |
| Share credit in Demat | Thursday, 31 Jul, 2025 |
| Listing Date | Friday, 01 Aug, 2025 |
Key Details
| Price Band | ₹82 to ₹84 Per Share |
|---|---|
| Lot Size | 1600 Shares |
| Face Value | ₹10 Per Equity Share |
| Total Issue Size | 7,000,000 Shares |
| Fresh Issue | 7,000,000 Shares |
| Issue Type | Fresh Issue |
| Listing At | SME Platform of BSE |
Share Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB | 50% |
| Retail | 35% |
| NII/HNI | 15% |
Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1600 | 134,400 |
| Retail (Max) | 1 | 1600 | 134,400 |
| S-HNI (Min) | 2 | 3200 | 268,800 |
| S-HNI (Max) | 7 | 11200 | 940,800 |
About Patel Chem Specialities Limited Company
Patel Chem Specialities Limited: Company Overview
Patel Chem Specialities Limited, established in 2008, is a manufacturer of cellulose-based excipients catering to the Pharmaceutical, Food & Beverages, Cosmetics, and other industries. We operate in the specialty chemicals sector, with a focus on producing a diverse range of cellulose-based excipients that serve as binders, disintegrants, thickeners, stabilizers, and gelling agents.
Our core products include Sodium Carboxymethyl Cellulose (Sodium CMC) marketed as "Rheollose®," Microcrystalline Cellulose (MCC) under the brand "Hindcel®," Sodium Starch Glycollate (SSG) available as "BlowTab® C" and "BlowTab® P," Croscarmellose Sodium ("Disolwell"), Calcium CMC ("Swellcal"), and Sodium Monochloro Acetate (SMCA). Our state-of-the-art manufacturing facilities in Vatva, Ahmedabad, and Talod, Himmatnagar, adhere to stringent quality control standards, including US-DMF, GMP, and ISO 9001:2015 certifications.
Led by experienced promoters Bhupesh Patel and Anshu Patel, the company has established a global presence, exporting to over 15 countries including the USA, Germany, UK, Japan, and China. Bhupesh Patel, Managing Director, brings over 25 years of pharmaceutical and nutraceutical industry experience to the company. Anshu Patel, Whole-Time Director, brings a decade of experience in the pharmaceuticals and nutraceutical industry and oversees the Company’s strategic plan and its operations across various functions.
Key Financial Highlights: (Figures in ₹ Crores)
- Revenue from Operations (Year ended March 31, 2024): ₹82.36
- Total Income (Year ended March 31, 2024): ₹82.72
- EBITDA (Year ended March 31, 2024): ₹12.02
- Profit After Tax (Year ended March 31, 2024): ₹7.66
Our key strengths include a diversified product portfolio, an experienced management team, and a global presence. We are committed to expanding our geographical reach and developing niche products to meet customer specifications.
Patel Chem Specialities Limited Financial Details
| Period Ended | 30 Jun 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 482394.00 | 469654.00 | 370818.00 | 234566.00 |
| Revenue | 270525.00 | 823616.00 | 693960.00 | 604846.00 |
| Profit After Tax | 26210.00 | 76562.00 | 28861.00 | 22790.00 |
| Net Worth | 221460.00 | 195249.00 | 118687.00 | 89827.00 |
| Reserves and Surplus | 21146.00 | 18524.90 | 10868.70 | 7982.70 |
| Total Borrowing | 144373.00 | 154550.00 | 117921.00 | 79148.00 |
₹ In Crore
Key Performance Indicator
| 4.50 | 39.21% | 11.49 | 0.79 | 39.21% | 45.06% |
Offer Objectives
The company intends to utilize the net proceeds from its fresh issue of equity shares to fund its capital expenditure requirements and for general corporate purposes. A major portion of the funds will be allocated to establishing a new manufacturing plant at Indrad, Mahesana for producing Croscarmellose Sodium (CCS), Sodium Starch Glycolate (SSG), and Calcium Carboxymethylcellulose (CMC). The total estimated cost for this project is ₹4314.78 lakhs (₹43.15 crore).
The new facility, covering 9,409 sq. mtrs, is expected to commercialize by March 2026 and will add a capacity of 6,012 MTPA, bringing the company's total installed capacity to 9,732 MTPA. The capital expenditure includes ₹1300 lakhs (₹13 crore) for civil and structural works, ₹226.56 lakhs (₹2.27 crore) for electricals and fittings, and ₹2788.22 lakhs (₹27.88 crore) for plant and machinery. The company acquired the land for ₹506.66 lakhs (₹5.07 crore) in July 2021.
The remaining proceeds, not exceeding 25% of the gross proceeds of the issue or ₹10 crore, whichever is lower, will be used for general corporate purposes. The funding requirements are based on current business plans and management estimates and are yet to be appraised by any bank or financial institution. The company may revise its funding requirements and deployment based on various factors.
Company Details
Address:
Plot No. 272/4 -5, Phase II, G.I.D.C Industrial Estate, Vatva Road, Ahmedabad 382445, Gujarat, India.
Phone: +91- 9712999854
Email: [email protected]
Website: http://www.patelchem.com
IPO Registrar Details
LINK INTIME INDIA PRIVATE LIMITED
Phone: +91 8108114949
Email: [email protected]
Website: http://www.linkintime.co.in
Offer Prospectus & Documents
Lead Managers
- CUMULATIVE CAPITAL PRIVATE LIMITED
- UNISTONE CAPITAL PRIVATE LIMITED
